Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Myovant On Path To Women’s Health Leadership, CEO Says

Feb 16 2017

• By Jessica Merrill

business

Related Content

Takeda Continues To Shed Pipeline Assets In Roivant Deal

Jun 07 2016

Myovant CEO Says Buoyant IPO Reflects High Interest In Women's Health

Oct 28 2016

Pfizer’s $14bn Medivation Buyout Shows How Far Pharma Will Go In Oncology

Aug 22 2016

Related Companies

Myovant Sciences Ltd.

Pfizer Inc.

Takeda Pharmaceutical Co. Ltd.

Roivant Sciences Ltd.

Medivation, Inc.

Johnson & Johnson

AbbVie Inc.

Additional Topics

Business Strategies Companies Leadership Commercial Gynecology & Urology BioPharmaceutical

More from Immunological

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window